跳至主要内容
临床试验/NCT02232750
NCT02232750已完成不适用

Evaluation of CPD (Cell Population Data) MNV (Mean Neutrophil Volume) as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

Ohio State University1 个研究点 分布在 1 个国家目标入组 1,320 人开始时间: 2014年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,320
试验地点
1
主要终点
We are measuring CBC (complete blood count) and MNV (Mean Neutrophil Volume)

研究概览

简要总结

The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (≥18 to 90 years)
  • Patients presenting to the Emergency Department
  • CBC (Complete Blood Count) with differential testing performed and CPD data retrieved

排除标准

  • Previously enrolled in this study

结局指标

主要结局

We are measuring CBC (complete blood count) and MNV (Mean Neutrophil Volume)

时间窗: approximately 10 months

Evaluate the clinical utility of CPD MNV as an aid in the diagnosis and risk assessment of Emergency Department patients for progression to sepsis, severe sepsis and septic shock.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elliott Crouser MD

Medical Director, Intensive Care Unit

Ohio State University

研究点 (1)

Loading locations...

相似试验